Latest Innovation News

Volt Resources has reached a key technical milestone by consistently producing ultra-high purity graphite using a proprietary, hydrofluoric acid-free process, paving the way for U.S.-based battery-grade graphite production.

Renascor Resources reports steady progress on its Purified Spherical Graphite demonstration plant in Adelaide, backed by a $5 million government grant, aiming to challenge China’s dominance in battery materials.

Credit Clear Limited has agreed to acquire UK debt collector ARC Europe for A$10.9 million, backed by a $20.75 million institutional placement led by Chair Paul Dwyer. The deal aims to accelerate growth by integrating Credit Clear’s digital platform into ARC’s established UK operations.

TZ Limited has turned down a non-binding offer from Quadient SA for its US Smart Locker subsidiary, Telezygology Inc., citing undervaluation and strategic importance of its Data Centre Security division. The company is now initiating a strategic review to explore future options for the business.

BlinkLab Limited has completed its U.S. pilot study for the Dx 1 smartphone-based autism diagnostic device, demonstrating strong accuracy and securing FDA alignment for its pivotal trial. The results mark a significant step toward transforming early neurodevelopmental diagnostics.

Codan Limited reported a strong FY25 with significant revenue and profit growth, bolstered by a key U.S. acquisition and a robust outlook for FY26 driven by defense spending and gold market strength.

Hazer Group has made significant strides in commercialising its methane pyrolysis technology, advancing key partnerships and strengthening its intellectual property portfolio amid a tightening global graphite market.

Adairs Limited has updated its first half FY26 sales and gross margin guidance, reflecting moderated growth and mixed brand performances as it prepares for a critical peak trading period.

4DMedical secures a major commercial breakthrough with Stanford University adopting its FDA-cleared CT, VQ™ technology, while its partnership with AstraZeneca rapidly scales lung screening across Brazil.

TrivarX has completed recruitment of 60 patients in its US veteran-focused mental health trial, advancing validation of its novel single-lead ECG algorithm for depression screening. Positive interim results from 27 patients set the stage for full data release and commercial discussions.

Noxopharm Limited has been granted its first US patent for the Sofra™ technology platform, marking a key milestone in its cancer immunotherapy research. This patent protects the company’s innovative immune-modulatory oligonucleotides, underpinning its expanding pipeline in a rapidly growing market.

Freelancer Limited reported a steady third quarter with operational profitability and notable growth in AI-related projects and Loadshift revenues, despite a year-on-year dip in overall marketplace volume.